FierceBiotech |
 Exonics to use CRISPR in an effort to treat majority of DMD boys
FierceBiotech Exonics Therapeutics has won $5 million in seed funding toward its goal of using cutting-edge new gene editing technology to help correct the majority of DMD mutations in young boys. The new CRISPR/Cas9 tech, which only began human testing in China ... CureDuchenne Ventures Commits $5M to Startup with CRISPR-Based DMD Therapy A CRISPR/Cas9 startup launches on the R&D frontier, working on a one-time fix for Duchenne MD CureDuchenne Ventures Invests $5 Million in Duchenne Gene Therapy |
from Health - Google News http://ift.tt/2mwbU5j
EmoticonEmoticon